New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 20, 2014
17:04 EDTSUPN, UTHRSupernus receives $2M milestone payment for launch of Orenitram
Supernus Pharmaceuticals (SUPN) announced that United Therapeutics Corporation (UTHR) has paid Supernus a $2M milestone payment under United Therapeutics' license agreement with Supernus. This payment was due upon the launch of Orenitram Extended-Release Tablets for the treatment of pulmonary arterial hypertension, in the United States. Orenitram utilizes a Supernus patented technology platform. In addition to the launch milestone, Supernus will receive royalties on net sales of Orenitram, and may become entitled to additional milestone payments.
News For SUPN;UTHR From The Last 14 Days
Check below for free stories on SUPN;UTHR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2014
07:17 EDTUTHRUnited Therapeutics price target raised to $150 from $120 at H.C. Wainwright
H.C. Wainwright raised its price target for United Therapeutics shares to $150 citing strong sales and positive prospects following the company's Q2 results. The firm reiterates a Buy rating on the stock.
July 29, 2014
06:07 EDTUTHRUnited Therapeutics reports Q2 EPS $2.30, consensus $1.75
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use